M2 macrophage polarisation
also: M2 macrophages, alternatively activated macrophages, pro-resolution macrophages
The pro-resolution, anti-inflammatory phenotype of macrophages that promotes tissue repair and dampens excessive immune responses.
Macrophages are not a single fixed cell type; they exist on a functional spectrum anchored at two poles. M1-polarised macrophages drive pro-inflammatory, bactericidal responses, while M2-polarised macrophages promote tissue repair, phagocytose cellular debris, and secrete anti-inflammatory cytokines such as IL-10 and TGF-β. In practice, most tissue macrophages occupy intermediate states, but the M1/M2 framework remains a useful research shorthand.
Why it matters in peptide research
Skewing the macrophage population toward an M2 phenotype is a central goal in models of chronic inflammation, fibrosis, and wound healing. When M1 activity dominates beyond the acute phase of injury, tissue damage accumulates and repair stalls. Peptides that accelerate the M1-to-M2 transition can therefore act as pro-resolution agents rather than simple immunosuppressants — a mechanistically important distinction, because immunosuppression broadly impairs pathogen clearance whereas pro-resolution signalling restores homeostasis without blunting pathogen defence.
TB-500, the synthetic form of the actin-sequestering protein thymosin beta-4, has been studied in the context of macrophage polarisation. Thymosin beta-4 upregulates IL-10, reduces TNF-α secretion, and promotes the expression of CD163 — a canonical M2 surface marker — in injured tissue. Preclinical wound-healing models consistently show earlier vascularisation and reduced scar tissue when thymosin beta-4 is present, outcomes consistent with a shift toward M2 activity.
Researchers should note that M2 polarisation also features in pathological contexts: tumour-associated macrophages (TAMs) are predominantly M2-like and support angiogenesis and immune evasion. This dual role underscores the importance of studying macrophage phenotype in well-defined injury or disease models rather than assuming M2 promotion is universally beneficial.
The M1/M2 distinction in more detail
The terminology of "M1" and "M2" is a simplification of a spectrum. In the canonical schema:
- M1 (classically activated) — induced by IFN-γ and LPS; secretes TNF-α, IL-1β, IL-6, IL-12, IL-23, reactive oxygen and nitrogen species. Pro-inflammatory, bactericidal, tumoricidal. Dominant in early acute inflammation.
- M2a (alternatively activated) — induced by IL-4 and IL-13; secretes IL-10, TGF-β, expresses arginase-1, CD206 (mannose receptor). Drives tissue repair, wound healing, helminth defence.
- M2b (regulatory) — induced by immune complexes and TLR ligands; intermediate cytokine profile.
- M2c (deactivated) — induced by IL-10 and glucocorticoids; strongly immunosuppressive.
- M2d (tumour-associated, TAM) — induced in the tumour microenvironment; pro-angiogenic and immunosuppressive in a way that supports tumour progression.
Recent single-cell transcriptomic work has shown that macrophages occupy a much richer phenotypic space than this schema captures, but the M1/M2 labels remain useful research shorthand.
Peptides and stacks that engage this axis
- TB-500 — thymosin β4 fragment; studied for promoting M2-associated cytokine profiles and accelerating resolution of sterile injury.
- KPV — α-MSH fragment with anti-inflammatory effects in colitis models, partly via macrophage modulation.
- BPC-157 — modulates inflammatory signalling in tissue-repair models.
- BPC-157 + TB-500 — combination evidence review.
- Wound healing phase mechanism map — where macrophage polarisation fits in the time-axis cascade.
- NF-κB inflammation mechanism map.
The dual-character problem
M2 polarisation is not universally beneficial. Tumour-associated macrophages (TAMs) are predominantly M2-like and support angiogenesis, immunosuppression, and tumour progression. The same polarisation phenotype that promotes wound healing in a sterile injury context can support oncogenic outcomes in an active-tumour context. Active or recently-treated cancer is one of the recurring contraindication categories for pro-repair peptides — see contraindication deep-dive.
Reading tip
When reading macrophage polarisation studies, check the marker panel used. Some papers rely only on a single cytokine (e.g., IL-10) to claim M2 polarisation; stronger evidence requires surface marker co-staining (CD206, CD163) plus functional assays such as phagocytosis capacity or efferocytosis rates. See: how to read peptide studies.